Cited by 171Cardiovascular Syncope and Autonomic DisordersHeart Rate Variability and Autonomic ControlVagus Nerve Stimulation Research

The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.

Acetylcholinesterase Inhibition Improves Tachycardia in Postural Tachycardia Syndrome

Open access

Abstract

Background— Postural tachycardia syndrome (POTS) induces disabling chronic orthostatic intolerance notable for an excessive increase in heart rate that occurs on standing. Many current therapeutic strategies focus on sympatholysis, but the alternative strategy of enhancing cardiovagal tone has not been studied. The objective of this study was to test the hypothesis that acetylcholinesterase inhibitors will attenuate the tachycardia and improve symptom burden in patients with POTS. Methods and Results— Seventeen patients with POTS underwent acute drug trials of pyridostigmine 30 mg orally and placebo, on separate mornings, in a randomized crossover design. Blood pressures, heart rate, and symptoms were assessed while patients were seated and after they had been standing for up to 10 minutes both before the study drug was given and at 2 and 4 hours after study drug. The heart rate was significantly lower at 2 hours after pyridostigmine than after placebo (100±16 versus 111±14 bpm, P =0.001). Pyridostigmine significantly decreased the standing heart rate from baseline (119±16 bpm) at 2 hours (104±16 bpm, P <0.001) and 4 hours (100±16 bpm, P <0.001) after administration. There was no significant change in blood pressure. The decrease in symptom burden within 4 hours after study drug was significantly greater with pyridostigmine than placebo (−10.4±14.0 AU versus 0.6±7.5 AU, P <0.025). Conclusions— Acute acetylcholinesterase inhibition significantly attenuated tachycardia in POTS. There was also an improvement in symptom burden with this promising therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.104.497594

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 1

  1. Singer W, Hines SM, Opfer-Gehrking TL, Low PA. Influence of acetylcholinesterase inhibition on baroreflex sensitivity in patients with orthostatic intolerance. Neurology. 2004; 62: A420.Abstract.

Cited by

Sorted by citations

Metadata

Authors
Raj, S. R., Black, B. K., Biaggioni, I., Harris, P. A., & Robertson, D.
Affiliations
Vanderbilt University (US)
Venue
Circulation
Published
2005-05-31
Volume
111
Issue
21
Pages
2734-2740
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2119590578
Cited by
171
References
25
Citations by year
2026: 11 · 2025: 11 · 2024: 12 · 2023: 6 · 2022: 10 · 2021: 8 · 2020: 7 · 2019: 8 · 2018: 9 · 2017: 7 · 2016: 8 · 2015: 6 · 2014: 11 · 2013: 13 · 2012: 10
FWCI
6.34
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Vanderbilt University (M01 RR00095)
  • Deutsches Krebsforschungszentrum
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (2P01-HL-56693, P01HL056693)
  • National Center for Research Resources (M01RR000095, M01-RR-00095, K23RR020783)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
Keywords
postural orthostatic tachycardia syndrome, acetylcholinesterase inhibitors, pyridostigmine, orthostatic intolerance, heart rate, symptom burden, drug trials
MeSH terms
Adult, Blood Pressure, Cholinesterase Inhibitors, Female, Heart Rate, Humans, Male, Middle Aged, Posture, Pyridostigmine Bromide, Tachycardia, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review